Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy

Laryngoscope

Volumn 116, Issue 8, 2006, Pages 1434-1438

  Mehrotra, Pallavi ^a   Gonzalez, Michael A ^b   Johnson, Sarah J ^c   Coleman, Nick ^b   Wilson, Janet A ^a   Davies, Barry R ^a   Lennard, Tom W J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Cancer; Cell cycle; Ki 67; Mcm 2; Thyroid

Indexed keywords

FORMALDEHYDE; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; PARAFFIN;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CELL LABELING; CONTROLLED STUDY; DISEASE MARKER; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NODULAR GOITER; PAPILLARY CARCINOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; THYROID CANCER; THYROID GLAND; TISSUE SECTION;

ADENOMA; CARCINOMA, PAPILLARY; CELL CYCLE PROTEINS; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NUCLEAR PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33746862012     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000225931.59644.93     Document Type: Article

References (15)

1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997;33:1075-1107.
2. Labib K, Kearsey SE, Diffley JFX. Mcm2-7 proteins are essential components of prereplicative complexes that accumulate cooperatively in the nucleus during G1-phase and are required to establish, but not maintain, the S-phase checkpoint. Mol Cell Biol 2001;12:3658-3667.
3. Mendez J, Stillman B. Chromatin association of human origin recognition complex, Cdc6 and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol 2000;20:8602-8612.
4. Stoeber K, Tisty TD, Happerfield L, et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001;114:2027-2041.
5. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999;5:2121-2132.
6. Gonzalez MA, Pinder SE, Callagy G, et al. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 2003;21:4306-4313.
7. Sington JD, Morris LS, Nicholson AG, Coleman N. Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma. Histopathology 2003;42:498-502.
8. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40:2-11.
9. Baisch H, Gerdes J. Simultaneous staining of exponentially growing versus plateau phase cells with the proliferationassociated antibody Ki67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet 1987;20:387-391.
10. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984;133:1710-1715.
11. van Heerdon JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a non threatening malignancy. Surgery 1992;112:1130-1138.
12. Collini P, Sampietro G, Pilotti S. Extensive vascular invasion is a marker of risk of relapse in encapsulated nonHurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 2004;44:35-39.
13. Erickson LA, Jin L, Goellner JR, et al. Pathological features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Mod Pathol 2000;13:186-192.
14. Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK. Immunohistochemical expression of cyclin D1, E2F1 and Ki67 in benign and malignant thyroid lesions. J Pathol 2002;198:157-162.
15. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol 2000;13:882-887.